Robert J Bertolini is Director of CHARLES RIVER LABORATORIES INTERNATIONAL, INC.. Currently has a direct ownership of 32,802 shares of CRL, which is worth approximately $6.6 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 953 shares (Common Stock) at a price of $228.41 per share, resulting in proceeds of $217,674. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.8K
0% 3M change
2.99% 12M change
Total Value Held $6.6 Million

ROBERT J BERTOLINI Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2024
BUY
Grant, award, or other acquisition
$217,674 $228.41 p/Share
953 Added 2.82%
32,802 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
1,132 Added 3.43%
31,849 Common Stock
May 11 2022
BUY
Grant, award, or other acquisition
-
980 Added 3.09%
30,717 Common Stock
May 07 2021
BUY
Grant, award, or other acquisition
-
603 Added 1.99%
29,737 Common Stock

Also insider at

BMY
BRISTOL MYERS SQUIBB CO Healthcare
RJB

Robert J Bertolini

Director
New York, NY

Track Institutional and Insider Activities on CRL

Follow CHARLES RIVER LABORATORIES INTERNATIONAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRL shares.

Notify only if

Insider Trading

Get notified when an Charles River Laboratories International, Inc. insider buys or sells CRL shares.

Notify only if

News

Receive news related to CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Track Activities on CRL